Although we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.

The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans and is often treated with a CPAP machine, but is often declined due to its ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

Georgia, Notre Dame fans make Sugar Bowl decision as game is postponed over terror attack A Little Boy Found a Strange Stone ...

The rent-to-own policy, in particular, epitomizes this broken system. It penalizes patients who depend on critical medical ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

What many dismiss as a mere nighttime nuisance often signals deeper health issues requiring medical attention. While snoring ...